 |
|
Dermal Lipofuscinosis Associated With Amiodarone TherapyReport of a Case
Robert A. W. Miller, MD, FRCP(C);
Alan T. J. McDonald, MD, FRCP(C)
Arch Dermatol. 1984;120(5):646-649.
Abstract
• Amiodarone hydrochloride is a noncompetitive adrenergic blocker used in the treatment of tachyarrhythmias. Its use in Europe and South America has been associated with cutaneous pigmentation thought to be caused by lipofuscin deposition in the dermis. We describe a similar case occurring in North America. A skin biopsy specimen from the patient was examined by light microscopy, fluoresence microscopy, and electron microscopy. From these examinations, a diagnosis of dermal lipofuscinosis was made.
(Arch Dermatol 1984;120:646-649)
Author Affiliations
From the Departments of Dermatology (Dr Miller) and Pathology (Dr McDonald), Victoria General Hospital and Dalhousie University, Halifax, Nova Scotia, Canada.
Footnotes
Accepted for publication July 1, 1983.
Reprint requests to 6088 Coburg Rd, Halifax, Nova Scotia, Canada B3H 124 (Dr Miller).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Photodistribution of Blue-Gray Hyperpigmentation After Amiodarone Treatment: Molecular Characterization of Amiodarone in the Skin
Ammoury et al.
Arch Dermatol 2008;144:92-96.
ABSTRACT
| FULL TEXT
Blue-Gray Discoloration of the Face
Klein et al.
Arch Dermatol 1989;125:417-418.
ABSTRACT
Pigmentation Induced by Quinidine Therapy
Mahler et al.
Arch Dermatol 1986;122:1062-1064.
ABSTRACT
Autofluorescence Emission Spectra of Dermal Lipofuscinosis Associated With Amiodarone Therapy
Dowson et al.
Arch Dermatol 1986;122:244-245.
ABSTRACT
Toxic Epidermal Necrolysis and Amiodarone Treatment
Bencini et al.
Arch Dermatol 1985;121:838-838.
ABSTRACT
|
